Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
06/2012
06/13/2012CN102491978A Method for preparing natural pigments, polysaccharide and saponin by utilizing disused asparagus resources
06/13/2012CN102491956A L-setastine hydrochloride and preparation method thereof
06/13/2012CN102488880A Human body massage liquid prepared from ginger essential oil, preparation method thereof, and massage liquid supplying apparatus
06/13/2012CN102488867A Novel application of pharmaceutical composition
06/13/2012CN102488855A Chinese medicine for treating chronic rejection of transplanted kidney
06/13/2012CN102488843A Composition for improving immunity and preparation method and application thereof
06/13/2012CN102488839A Extraction method for saponins of rhizoma polygonati
06/13/2012CN102488822A Traditional Chinese medicine composition used for raising immunity of broiler chickens and its preparation method
06/13/2012CN102488803A Preparation method for superfine bupleurum powder under normal temperature and special bidirectional airflow sieving machine
06/13/2012CN102488758A Traditional Chinese medicine composition for treating allergic rhinitis and preparation method thereof
06/13/2012CN102488720A Preparation method for submicron pine needle powder at normal temperature and special bidirectional air-flow screening machine
06/13/2012CN102488713A Method for preparing sheep placenta extract and sheep placenta hydrolyzed collagen concentrated solution
06/13/2012CN102488678A Application of embelin to preparation of medicament for treating autoimmune disease
06/13/2012CN102488627A Radiation-resistant and moisture-retention make-up base, lotion and water
06/13/2012CN102488605A Acupuncture point massaging medicine ball
06/13/2012CN102488251A Sea cucumber gelatin, preparation method thereof, medicine or health product containing sea cucumber gelatin, and application of sea cucumber gelatin
06/13/2012CN102058744B Chinese medicinal composition for treating malignant tumor and preparation method thereof
06/13/2012CN101993888B Method for producing and recombining main allergic protein Hum j 3 of Humulus scandens by induced secretion expression
06/13/2012CN101966165B Solid effervescent mixture for the oral absorption
06/13/2012CN101926840B Ultrafine powder of echinacea and preparation method and application thereof
06/13/2012CN101874779B Fructose diphosphate sodium liposome solid preparation and novel application thereof
06/13/2012CN101810844B External plaster for preventing disease and manufacturing method thereof
06/13/2012CN101636397B Urea compounds, preparation methods and pharmaceutical uses thereof
06/13/2012CN101461794B Use of frangula emodin in immuno suppressive medicament for resisting transplant rejection
06/13/2012CN101331150B Human monoclonal antibody human CD134 (OX40) and methods of making and using same
06/13/2012CN101297667B Dandelion health-care tea and preparing process thereof
06/12/2012US8198483 Phenethanolamine derivatives for treatment of respiratory diseases
06/12/2012US8198400 Liposomal vaccines containing immunogenic lipopeptides from tuberculosis, malaria, and hepatitis B peptides
06/12/2012US8198295 Benzonaphthyridines
06/12/2012US8198286 Sodium channel blockers
06/12/2012US8198272 Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments
06/12/2012US8198078 Fucosyl transferase gene
06/12/2012US8197839 A miniature coated tablet or covered rod implant; smaller size and larger payloads than immediate release tablets; veterinary medicine
06/12/2012US8197826 Probiotic for enhancing immune response
06/12/2012US8197820 HIV-1 Tat, or derivatives thereof for prophylactic and therapeutic vaccination
06/12/2012US8197814 Method for treating the Th2-mediated disease
06/12/2012US8197813 Human antibodies that bind human TNFα
06/12/2012CA2475331C Synthesis of indole thiazole compounds as ligands for the ah receptor
06/12/2012CA2404325C Immunotherapeutic methods and compositions
06/12/2012CA2363269C Dna vaccination for treatment of autoimmune disease
06/12/2012CA2262756C A tumor necrosis factor related ligand
06/10/2012CA2761402A1 Sheet-form preparation and method for producing the same
06/07/2012WO2012075490A2 Anti-podoplanin antibodies and methods of use
06/07/2012WO2012075291A1 Compositions and methods for treating foxp3+ treg related diseases
06/07/2012WO2012074116A1 IMMUNOTHERAPY USING ALLO-NKT CELLS, CELLS FOR IMMUNOTHERAPY IN WHICH α CHAIN OF T-CELL RECEPTOR (TCR) GENE HAS BEEN REARRANGED TO UNIFORM Vα-Jα, AND BANKING OF NKT CELLS DERIVED FROM SAID CELLS
06/07/2012WO2012074097A1 Anti-cd33 antibody
06/07/2012WO2012074068A1 Method for producing hematopoietic stem cells using pyrazole compound
06/07/2012WO2012073856A1 Oil-in-water emulsion composition containing difluprednate and tobramycin
06/07/2012WO2012073459A1 Tomm34 peptides and vaccines including the same
06/07/2012WO2012072268A2 Tolerance induction or immunosupression to prevent in particular graft-versus-host-disease (gvhd) by short-term pre-incubation of transplanted cell suspensions, tissues or organs coated with ligands to cell surface molecules
06/07/2012WO2012071772A1 :grape wine of nutritional enhancement
06/07/2012US20120142774 Emulsifying preparation
06/07/2012US20120142772 Benzo Lipoxin Analogues
06/07/2012US20120142750 Indoleamine 2,3-dioxygenase pathways in the generation of regulatory t cells
06/07/2012US20120142744 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
06/07/2012US20120142740 Novel alkene derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142739 Novel oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142736 Novel pyridine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142735 Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]- 1h-indol-3-yl]-methanones
06/07/2012US20120142733 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of ccr2
06/07/2012US20120142732 Heteroaryls and uses thereof
06/07/2012US20120142729 KAT ll INHIBITORS
06/07/2012US20120142716 4-pyrimidinesulfamide derivative
06/07/2012US20120142711 Acid-labile trigger units
06/07/2012US20120142708 Substituted pyridine urea compounds
06/07/2012US20120142707 Modified c-3 betulinic acid derivatives as hiv maturation inhibitors
06/07/2012US20120142696 Substituted indole/indazole-pyrimidinyl compounds
06/07/2012US20120142692 Antifolate combinations
06/07/2012US20120142687 Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity
06/07/2012US20120142683 Pyrimidine substituted purine compounds as kinase (s) inhibitors
06/07/2012US20120142678 Novel compound useful for the treatment of degenerative and inflammatory diseases
06/07/2012US20120142677 Pyrrolidine Compounds Which Modulate The CB2 Receptor
06/07/2012US20120142671 Benzamides and nicotinamides as syk modulators
06/07/2012US20120142667 Pyrimidine derivatives as zap-70 inhibitors
06/07/2012US20120142666 Azetidine 2-Carboxamide Derivatives Which Modulate The CB2 Receptor
06/07/2012US20120142664 Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142663 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142662 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142661 Novel oxime azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142653 C-28 amides of modified c-3 betulinic acid derivatives as hiv maturation inhibitors
06/07/2012US20120142651 Method of treatment of allergic rhinitis
06/07/2012US20120142642 Novel oxime derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142640 Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
06/07/2012US20120142639 Oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142620 Core 2 glcnac-t inhibitors
06/07/2012US20120142615 Methods related to the treatment of neurodegenerative and inflammatory conditions
06/07/2012US20120142600 Analogs of ShK Toxin and their Uses in Selective Inhibition of Kv1.3 Potassium Channels
06/07/2012US20120142580 Opioid receptors stimulating compounds (thymoquinone, nigella sativa) and food allergy
06/07/2012US20120141602 Systems containing magnetic nanoparticles and polymers, such as nanocomposites and ferrofluids, and applications thereof
06/07/2012US20120141590 Technology for the Preparation of Microparticles
06/07/2012US20120141585 Immunomodulatory compositions comprising a polymer matrix and an oil phase
06/07/2012US20120141577 Linear expression cassette vaccines
06/07/2012US20120141564 Compositions and methods of treating inflammation
06/07/2012US20120141560 Tumor and infectious disease therapeutic compositions
06/07/2012US20120141558 Alginate-based nanofibers and related scaffolds
06/07/2012US20120141542 Method of using punicic acid to enhance immune response and prevent metabolic disorders
06/07/2012US20120141541 Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
06/07/2012US20120141540 Drug Delivery System
06/07/2012US20120141539 Methods for modulating toll-like receptor mediated activation of cells of the innate system by modulating xbp-1 activity
06/07/2012US20120141538 Modulators of the cx3cri receptor and therapeutic uses thereof
1 ... 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 ... 1172